We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$22.7B
AUM Growth
+$1.49B
Cap. Flow
-$446M
Cap. Flow %
-1.97%
Top 10 Hldgs %
29.86%
Holding
610
New
38
Increased
168
Reduced
251
Closed
125

Sector Composition

Rank Sector Weight
1 Technology 29%
2 Healthcare 21.84%
3 Financials 10.81%
4 Consumer Discretionary 8.93%
5 Communication Services 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
51
Freeport-McMoran
FCX
$90B
$78.6M 0.35%
1,846,974
+13,388
+0.7% +$494K
CMCSA icon
52
Comcast
CMCSA
$85B
$78.1M 0.34%
1,782,021
-156,138
-8% -$6.69M
PFE icon
53
Pfizer
PFE
$143B
$74.7M 0.33%
2,595,309
+321,372
+14% +$9.71M
VZ icon
54
Verizon
VZ
$195B
$73.3M 0.32%
1,944,693
-98,296
-5% -$3.48M
C icon
55
Citigroup
C
$222B
$69.6M 0.31%
1,352,808
-91,337
-6% -$4.04M
PBR.A icon
56
Petrobras Class A
PBR.A
$111B
$68.2M 0.3%
4,465,772
-1,367,407
-23% -$19.6M
BTI icon
57
British American Tobacco
BTI
$131B
$65.3M 0.29%
2,228,698
+113,691
+5% +$3.46M
CSCO icon
58
Cisco
CSCO
$457B
$64.3M 0.28%
1,272,798
+596,763
+88% +$30.5M
CVX icon
59
Chevron
CVX
$392B
$62.3M 0.28%
417,747
+33,483
+9% +$5.06M
GSK icon
60
GSK
GSK
$104B
$62.2M 0.27%
1,678,949
+412,505
+33% +$14.8M
CVS icon
61
CVS Health
CVS
$133B
$61.8M 0.27%
782,392
-55,527
-7% -$3.95M
CLNE icon
62
Clean Energy Fuels
CLNE
$427M
$61.6M 0.27%
16,086,394
+2,333,024
+17% +$8.5M
REGN icon
63
Regeneron Pharmaceuticals
REGN
$78.5B
$58.9M 0.26%
67,100
+9,160
+16% +$7.54M
ENPH icon
64
Enphase Energy
ENPH
$4.96B
$58.1M 0.26%
439,943
+205,856
+88% +$21.8M
COF icon
65
Capital One
COF
$128B
$57.8M 0.26%
440,970
-49,612
-10% -$5.35M
XOM icon
66
ExxonMobil
XOM
$644B
$57.2M 0.25%
572,336
+9,273
+2% +$975K
VOD icon
67
Vodafone
VOD
$36.3B
$56.7M 0.25%
6,520,776
+1,640,313
+34% +$15M
MMM icon
68
3M
MMM
$90.9B
$56.3M 0.25%
616,359
+5,757
+0.9% +$462K
F icon
69
Ford
F
$58.5B
$55.6M 0.25%
4,558,885
+459,467
+11% +$5.11M
CTSH icon
70
Cognizant
CTSH
$24.9B
$54.9M 0.24%
726,370
+37,050
+5% +$2.56M
HPQ icon
71
HP
HPQ
$24.9B
$54.4M 0.24%
1,806,778
-153,290
-8% -$4.29M
PXD
72
DELISTED
Pioneer Natural Resource Co.
PXD
$54M 0.24%
+240,096
New +$56.3M
DFS
73
DELISTED
Discover Financial Services
DFS
$53.1M 0.23%
472,576
-14,825
-3% -$1.37M
GM icon
74
General Motors
GM
$80.4B
$52.9M 0.23%
1,473,617
+136,547
+10% +$4.22M
ON icon
75
ON Semiconductor
ON
$31.8B
$52.9M 0.23%
633,108
+421,803
+200% +$33.1M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2023 Portfolio in Review

As of Q4 2023, Grantham, Mayo, Van Otterloo & Co (GMO) held 610 positions worth $22.7B, up 7% from $21.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2023 filing shows 38 new, 168 increased, 251 reduced and 125 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 240,096 shares worth $54M. The largest sale was Adobe, an estimated $302M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2023 buy was Pioneer Natural Resource Co.: 240,096 shares worth $54M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Texas Instruments in Q4 2023, an estimated $101M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2023 reduction was Lam Research, cutting an estimated $74.4M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Adobe in Q4 2023, selling an estimated $302M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 30% of its $22.7B portfolio in Q4 2023.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 38 new positions and closed 125 in Q4 2023.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 7% quarter-over-quarter to $22.7B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2023, filed 13 Feb 2024.